Announcements Trials
Browse Landscape

Status

Unknown 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 83Observational 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Pancreatic Neoplasms 2Stomach Neoplasms 1Liver Neoplasms 1Gallbladder Neoplasms 1Fallopian Tube Neoplasms 1Esophageal Neoplasms 1Colonic Neoplasms 1Biliary Tract Neoplasms 1

Interventions

Blood Specimen Collection 17Pancreaticoduodenectomy 15Surveys and Questionnaires 11Endoscopic Ultrasound-Guided Fine Needle Aspiration 10Observation 9Biopsy 8Specimen Handling 6Pancreatectomy 6Gemcitabine 6Data Collection 6Surgical Procedures, Operative 5Magnetic Resonance Spectroscopy 5Endosonography 5Electroporation 5Biopsy, Fine-Needle 5Neoadjuvant Therapy 4Magnetic Resonance Imaging 4Liquid Biopsy 4Interviews as Topic 4Immunologic Techniques 4Immunohistochemistry 4Drug Therapy 4folfirinox 3Fluorouracil 3Cholangiopancreatography, Endoscopic Retrograde 3Albumin-Bound Paclitaxel 3irinotecan sucrosofate 2Taxes 2Sulfonylurea Compounds 2Secretin 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Observational × Pancreatic Neoplasms × Taxes × Clear all
NCT04133155 2020-03-13

Retrospective Analysis of 2nd-line Nab-Paclitaxel + Gemcitabine After 1st-line FOLFIRINOX in Pancreatic Cancer

Asan Medical Center

Completed
103 enrolled
Gastrointestinal

Pancreatic Neoplasms

NCT03668418 2018-09-12

xenoZ

University of Pisa

Unknown
120 enrolled
Gastrointestinal

Biliary Tract Neoplasms, Colonic Neoplasms, Esophageal Neoplasms, Gallbladder Neoplasms, Liver Neoplasms, Pancreatic Neoplasms, Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡